Camargo

MAY 2, 2021

Advances in scientific knowledge and growth in the cell and gene therapy space have led to a new and exciting era of medicine for patients, as well as a new motivation for regulators to provide clear, efficient pathways for product developers. Note: Some medicines are in more than one category.

Gene Therapy 155

Gene Therapy Gene Packaging Packaging 155

The Pharma Data

SEPTEMBER 8, 2021

TIB Molbiol is a biotech company that has supplied the global market with reagents for research and medical diagnostics for over 30 years. The majority of assays are used to test for infectious diseases. They are available as modular kits, enabling the creation of symptomatic panels by combining assays, including emerging pathogens.

Genotype 52

Genotype Reagent Genetics Research 52

Drug Discovery World

JULY 18, 2023

Rolf Turk , Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies. These efforts, along with many others, are opening doors for new possibilities in translational medicine. parvovirus B19, Flaviviridae, Ebola, and Coronaviridae), DNA viruses (e.g.,

DNA 98

DNA Genome Genomics RNA 98

Advarra

NOVEMBER 29, 2022

However, despite the promise of these therapies, the regulations governing them lag the science, which in turn hinders the clinical translation of these novel medicines. The FDA recently announced a new initiative as part of its NIH Accelerating Medicines Partnership Program. But review issues are not the only problems.

Gene Therapy 52

Gene Therapy Gene Production Clinical Trials 52

The Pharma Data

MARCH 16, 2022

3, and Delta ([link] About TIB Molbiol TIB Molbiol is a subsidiary of Roche Diagnostics that has supplied the global market with reagents for research and medical diagnostics for over 30 years. These kits can detect and differentiate between Omicron subvariants BA.1, The majority of assays are used to test for infectious diseases.

In-Vitro 52

In-Vitro Genotype Reagent Protein 52

Drug Discovery World

FEBRUARY 15, 2023

Genetically modified T cells stimulated with IL2 are now administered as cell therapy for multiple cancer cell types with beneficial results 3,4. Genetically engineered mouse models (GEMM) recapitulate the stromal biology of different human cancers including the tumour microenvironment that regulates the disease process.

Research 52

Research In-Vitro In-Vivo Development 52

The Pharma Data

MARCH 13, 2021

HAE is a rare genetic disorder that results in recurrent attacks of oedema – swelling – in various parts of the body, including the abdomen, face, feet, genitals, hands and throat. The reagents used in the aPTT laboratory test initiate intrinsic coagulation through the activation of plasma kallikrein in the contact system.

Drugs 52

Drugs Antibody Production Medicine 52

Drug Discovery World

MARCH 13, 2023

Between the 24 therapies already approved by the FDA 1 and a marked increase in clinical trials, widespread accessibility to precision medicine feels within reach. Before 2019, CGT drug developers still had a young, academic mindset, ordering reagents, materials, and equipment haphazardly and assuming they would show up when needed.

Gene Therapy 52

Gene Therapy Gene Manufacturing Development 52

Drug Discovery World

JUNE 6, 2023

He is also a professor of medicine and immunology at the University of Washington School of Medicine. We’re still seeing those at the meeting at the moment”, he said, and thinks they still hold great promise for patients the better we understand patient genetics.

Protein 52

Protein DNA RNA Research 52

XTalks

OCTOBER 19, 2023

This could involve tweaking experimental conditions, changing reagents or redesigning the assay. There is also an increasing focus on personalized and precision medicine, where treatments are tailored to individual patients based on genetic or molecular data, which requires assays to detect and quantify these unique markers.

Scientist 59

Scientist Development Research Compliance 59

The Pharma Data

JULY 11, 2021

Hereditary angioedema (HAE) is a rare genetic disorder that results in recurring attacks of oedema – swelling – in various parts of the body, including the abdomen, face, feet, genitals, hands and throat. Based on the characteristics of lanadelumab, no pharmacokinetic interactions with co-administered medicinal products is expected.

Allergies 52

Allergies Antibody Recombinant DNA Technology Production 52

Drug Discovery World

JUNE 14, 2023

Besides looking at donor characteristics, our platform, which we call Excellos 360TM, includes the assessment of metabolic and effector potential of cells, and genetic analysis. According to the spokesperson, blood donorship is hugely important for the development of new and potentially transformative macrophage cell therapies.

Manufacturing 52

Manufacturing Production Gene Therapy Development 52

XTalks

OCTOBER 1, 2020

Prior to starting Fountain Therapeutics in 2018, with co-founders Tom Rando, MD, PhD and Tom Cheung, PhD, Dr. Rodgers was an assistant professor at The Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at the Keck School of Medicine of The University of Southern California (USC).

Scientist 52

Scientist In-Vitro Research Life Science 52